Bicnu (carmustine recalls

The FDA has published 1 recall involving Bicnu (carmustine since 2012. The latest was reported on 31 Oct 2012. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2012

Last 12 months0reported

Class I1100% of total

Ongoing0latest 31 Oct 2012

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 1 100%Class II 0 0%Class III 0 0%

Why bicnu (carmustine is recalled

Potency & Assay1100%

Companies

Bristol-myers Squibb1100%

By year

20121100%

All bicnu (carmustine recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
31 Oct 2012Drug	CLASS I	BiCNU (Carmustine for injection) 100 mg and Diluent recalled	Bristol-myers Squibb	Potency & Assay	Nationwide

Should you stop taking Bicnu (carmustine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.